Searchable abstracts of presentations at key conferences in endocrinology

ea0013p149 | Diabetes, metabolism and cardiovascular | SFEBES2007

Metabolic cage studies reveal that mice require 5 days for acclimatisation: establishing normal urinary and blood biochemistry values in BALB/c and C3H/HeH inbred mouse strains

Stechman Michael , Ahmad Bushra , Loh Nellie , Reed Anita , Hough Tertius , Bentley Liz , Cox Roger , Brown Steve , Thakker Rajesh

Inbred laboratory mice are widely used to generate, by homologous recombination, transgenic and chemical mutagenesis routes, genetic models of human disease. However, physiological studies of such models are hampered by the lack of normal ranges for serum and urinary biochemistry, particularly in relation to acclimatisation following placement in metabolic cages. To establish such values, we investigated urinary and serum parameters in forty, 24–30 week-old C3H/HeH, BALB/...

ea0007p279 | Clinical case reports | BES2004

A novel 17 alpha hydroxylase mutation (CYP 17) associated with a pelvic germ cell tumour

Brooke A , Ahmad T , Taylor N , Shepherd J , Lin L , Achermann J , Rumsbey G , Gore M , Monson J

A 17 year old phenotypically female Middle Eastern patient presented with a short history of abdominal pain. Laparotomy and biopsy confirmed extensive mixed germ cell tumour with yolk sac elements. After referral to London, remission was achieved with 6 cycles of Bleomycin, Etoposide and Cisplatinum (alpha feta protein decreasing from 12 714 to 5 milli units per litre). Examination revealed short stature, absent pubertal development and primary amenorrhoea. She had palmar, buc...

ea0003p5 | Bone | BES2002

Changes in parathyroid hormone sensitivity and rhythmicity and its effects on bone metabolism following growth hormone replacement in adult growth hormone deficient patients

Ahmad A , White H , Thomas J , Clewes A , Hopkins M , Guzder R , Ibrahim H , Durham B , Vora J , Fraser W

BACKGROUND: Adult Growth Hormone Deficiency (AGHD) is associated with reduced bone mineral density (BMD). PTH plays an important role in bone metabolism and reports have suggested target cell insensitivity to PTH as a contributor to the changes in bone turnover seen in AGHD. Although growth hormone replacement (GHR) increases BMD, the underlying mechanisms remain unclear.OBJECTIVES: To determine the effect of GHR on 24-hour PTH profiles, phosphocalcium ...

ea0056p668 | Neuroendocrinology | ECE2018

Cigarette smoking and neuroreceptors genetic variations: a handshake between genetic and environmental factors leading to nicotine addiction

Zafar Muhammad Mobeen , Ahmad Imtiaz , Raja Muhammad Saqlain , Kiani Shagufta , Ahmed Muhammad Sheeraz , Raza Shakeel , Gulfraz Muhammad , Kaukab Ghazala

Cigarette smoking is the major cause of disease related deaths in the world. Cigarette smoke contains many harmful chemicals, among them nicotine is the most potent one. The root cause of smoking hazards is nicotine addiction or dependence (ND). Environmental as well as genetic factors are reported to influence smoking which leads to nicotine addiction in all age groups especially. Neurexin1 is a cell adhesion protein important for synapse formation and CHRNB4 is chol...

ea0056p669 | Neuroendocrinology | ECE2018

Association of OPRD1 rs569356 SNP with Stress Response in opioid addicts

Rashid Faiqa , Zafar Muhammad Mobeen , Ahmed Imtiaz , Jabeen Shagusta , Ahmad Muhammad Sheeraz , Minhas Nasir Mehmood , Kaukab Ghazala

As a lingering, often deteriorating brain disease, addiction causes neurotic drug seeking and utilization along with injurious significances to the addicts and to those living around them. Biological, genetic and a number of intrinsic and extrinsic environmental constituents are most vital in entire risk factors of drug addiction. Among addictive drugs opioid dependence is considered as the most deliberated drug abuse disorder and a major social dilemma worldwide. Opioids indu...

ea0090p82 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Testosterone serum levels predict the severity of metabolic dysfunction associated fatty liver disease (MAFLD) in hypogonadal men

Santi Daniele , Spaggiari Giorgia , Nascimbeni Fabio , Lugari Simonetta , Felicani Cristina , Dalla Valentina Leonardo , Ahmad Ali , Raffaele Michele Granata Antonio , Andreone Pietro , Simoni Manuela

Background: Metabolic dysfunction associated fatty liver disease (MAFLD), the leading cause of chronic liver disease, is defined as the presence of hepatic steatosis and metabolic risk factors. Both testosterone and estradiol seem to have a pivotal role in hepatic lipid homeostasis, although underlying mechanisms are still unclear. Low testosterone serum levels result independently associated with MAFLD, but no studies so far evaluated MAFLD prevalence and severity in hypogona...

ea0044oc1.4 | Early Career Oral Communications | SFEBES2016

The urinary steroid metabolome as a non-invasive tool to stage non-alcoholic fatty liver disease

Moolla Ahmad , Amin Amin , Hughes Bev , Arlt Wiebke , Hassan-Smith Zaki , Armstrong Matt , Newsome Philip , Shah Tahir , Van Gaal Luc , Verrijken An , Francque Sven , Biehl Michael , Tomlinson Jeremy

Introduction: Dysregulation of glucocorticoid (GC) metabolism is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). The only available treatment for NAFLD is weight loss and the gold standard diagnostic test is liver biopsy, which is invasive and resource intensive. NAFLD ranges from simple steatosis, to inflammation (steatohepatitis/NASH), fibrosis and cirrhosis. It may be regarded as the hepatic manifestation of the metabolic syndrome and is strongl...

ea0044oc5.3 | Diabetes Mellitus and Metabolism | SFEBES2016

Depot specific transcriptional signatures of adipose tissue in sheep and humans during early life

Fainberg Hernan , Ojha Shalini , Alhaddad Ahmad , Alagal Reham , Birtwistle Mark , Davies Graeme , Castellanos Marcos , May Sean , Pelella Giussepe , Lotto Attilio , Sacks Harold , Budge Helen , Symonds Michael

The identification and characterisation of unique gene profiles expressed in specific adipose tissue depots around the body could provide novel insights on fat development.We report a comprehensive analysis of transcriptome from the five major (epicardial, pericardial, perirenal, sternal and omental) adipose depots from one week old sheep. This study also provides an integrated view of the preservation and differences between mitochondrial gene co-expres...

ea0041gp173 | Receptors & Signalling | ECE2016

The changing ‘steroid metabolome’ across the spectrum of non-alcoholic fatty liver disease

Moolla Ahmad , Amin Amin , Hughes Bev , Arlt Wiebke , Hassan-Smith Zaki , Armstrong Matt , Newsome Philip , Shah Tahir , Van Gaal Luc , Verrijken An , Francque Sven , Biehl Michael , Tomlinson Jeremy

Introduction: Dysregulated glucocorticoid (GC) metabolism has been implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). NAFLD extends from simple steatosis, to inflammation (steatohepatitis/NASH), fibrosis and consequent cirrhosis. It is often regarded as the hepatic manifestation of the metabolic syndrome and is independently associated with increased liver and cardiovascular mortality. Changes in GC metabolism have thus far been described in small num...

ea0061p002 | (1) | OU2019

Metabolic changes post Roux-En-Y Gastric Bypass: one year prospective study

Alexiadou Kleopatra , Behary Preeshila , Cuenco Joyceline , Tharakan George , Anyiam Oluwaseun , Hope David , Alessimii Haya , Choudhury Sirazum , Doyle Chedie , Rabie Ahmad , Ahmed Ahmed , Bloom Steve , Tan Tricia

Background: Bariatric surgery is currently the most effective treatment for weight loss. Its metabolic effects of weight loss and improvement of type 2 diabetes are mediated mainly through the postprandial elevation of gut hormones such as GLP-1, which suppresses food intake and improves insulin secretion.Aim: To characterize the longitudinal changes in fasting and postprandial secretion of glucose, insulin and gut hormones (GLP-1 and GIP) in patients be...